𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pulmonary hypertension associated with sickle cell disease: Clinical and laboratory endpoints and disease outcomes

✍ Scribed by Laura M. De Castro; Jude C. Jonassaint; Felicia L. Graham; Allison Ashley-Koch; Marilyn J. Telen

Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
244 KB
Volume
83
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Cerebrovascular disease associated with
Cerebrovascular disease associated with sickle cell pulmonary hypertension
✍ Gregory J. Kato; Matthew Hsieh; Roberto Machado; James Taylor VI; Jane Little; J πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 191 KB πŸ‘ 1 views

In patients with sickle cell disease, anemia is a recognized risk factor for stroke, death, and the development of pulmonary hypertension. We have proposed that hemolytic anemia results in endothelial dysfunction and vascular instability and can ultimately lead to a proliferative vasculopathy leadin

Pulmonary arterial hypertension and left
Pulmonary arterial hypertension and left-sided heart disease in sickle cell disease: Clinical characteristics and association with soluble adhesion molecule expression
✍ Elizabeth S. Klings; Demedrick Anton Bland; Dara Rosenman; Stephanie Princeton; πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 194 KB πŸ‘ 1 views

## Abstract Pulmonary hypertension (PH), a risk factor for mortality in sickle cell disease (SCD), has pathologic features of both pulmonary arterial hypertension (PAH) and PH related to left‐sided heart disease (LHD) suggesting a link between these two entities. We hypothesized that both are chara